Alcentra Capital Corp
Latest Alcentra Capital Corp News and Updates
Company & Industry Overviews Prospect Capital’s Ratings: What Wall Street Analysts Have to Say
Although Prospect Capital (PSEC) has been delivering decent returns to investors, there has not been much change in the analysts’ ratings.Company & Industry Overviews Prospect Capital’s Increasing Valuations in 2017
Analysts have given PSEC a one-year price target of $8.50 from the current price level, reflecting 0.7% growth.Company & Industry Overviews Prospect Capital Adopts a Conservative Approach in Fiscal 3Q17
Prospect Capital’s (PSEC) originations decreased in fiscal 3Q17 to $449.6 million compared to $469.5 million in fiscal 2Q17.Company & Industry Overviews Prospect Capital’s Disappointing Performance in Fiscal 3Q17
Prospect Capital (PSEC) reported a decline in its net investment income in its fiscal 3Q17 earnings. Analysts expect PSEC’s fiscal 4Q17 EPS to reach $0.20, representing no change from fiscal 3Q17.